2 results

• Skysona Blood Cancer Side Effects Lead to New FDA Restrictions

  August 11, 2025

  Martha Garcia

  The FDA has added a black box warning to the gene therapy drug Skysona after discovering more patients developed blood cancer than previously believed.

• Skysona Blood Cancer Risks Result in FDA Investigation Into Gene Therapy Treatment

  December 2, 2024

  Martha Garcia

  Federal health officials are investigating a potential link between the gene therapy Skysona and blood cancers, after clinical trials identified several patients who developed serious side effects in the months following treatment, including blood cancers and leukemia.